During the current pandemic, it may be difficult to keep pace with the rapid developments in tests, treatments and vaccines being studied for potential widespread use as approved technologies and therapies. You might read these news reports and wonder what is a “Phase 3 clinical trial” or an “emergency use authorization,” and why are these stages of approval by the U.S. Food and Drug Administration (FDA) important? Read on for explanations of common regulatory terms and phrases to help you understand medical research news.
Sutter participates in international HIV prevention study of cabotegravir, bringing new science to advance care at East Bay Advanced Care.
Shining Light on Mental Health: Research at Sutter Helps Reimagine the Future of Mental Health for At-risk Youth
As the novel coronavirus pandemic ushers in uncertainty that may evoke anxiety, depression or other mental health concerns for today’s youth, what would a new vision for their mental health look like? New screening tools for early detection of severe depression and suicide risk, as well as a novel program called Youth Mental Health Reimagined may be part of the path forward.
Rural counties struggle to attract well-trained primary-care, family physicians. Sutter Health developed a program to help solve this, and it is now on track to start next year.
SAN FRANCISCO — California Governor Gavin Newsom has made it clear in recent weeks that the State must greatly increase COVID-19 testing in order to re-open. Testing provides critical information to public health and government officials to help slow the spread of COVID-19. In order to achieve the governor’s goal of 60,000 tests performed per …
Paying it Forward: Sutter Teams with Vitalant to Offer COVID-19 Survivor-Donated Blood Plasma to Patients
New research suggests blood plasma collected from people who have recovered from COVID-19 may help treat patients with severe cases of the disease. Learn how Sutter’s new partnership with Vitalant will deliver this ground-breaking care to patients.
Stephen H. Lockhart, M.D., Sutter Health chief medical officer and executive sponsor of Sutter’s Environmental Stewardship Program, shares his thoughts on how everyone can care for our planet today and after COVID-19 passes.
When the Spanish flu hit Northern California, Sacramento had few options to care for its sick and dying population. So 17 local physicians decided to do something about it.
When a global health challenge began endangering communities across Northern California, researchers at Sutter started brainstorming potential solutions to deliver much-needed treatment to people infected with the novel coronavirus. Learn how clinical trials and other research at Sutter are helping bring top-quality care to our patients and communities.
SAN FRANCISCO—Imagine if you were ordered to shelter in place and your only option was a homeless shelter. How would you get care for your existing health conditions? For low-income or homeless people who live in San Francisco’s Tenderloin neighborhood, the coronavirus outbreak is making what was already a difficult situation even more challenging. Fortunately …